Probiotika & Darmgesundheit

BB-12's strength is breadth: it's approved and used across the widest age range of any commercial probiotic strain, from infant formula through senior nutrition, and has been in continuous commercial use since 1986. If you're formulating for a broad or age-diverse market rather than a single demographic, that track record carries real weight with regulators and retail buyers alike. As a Bifidobacterium — a genus underrepresented in most commercial probiotic blends compared to Lactobacillus species — BB-12 is frequently selected specifically to diversify a multi-strain formulation's genus profile, including pairing with LGG. It shows the same reliable gastric and bile tolerance required for shelf-stable formats, and at 800 Billion CFU/g we supply it at a concentration well suited to high-potency finished products or as a strong base for custom-blended formulations. Full documentation supplied with every batch: Certificate of Analysis, microbial identity confirmation, and independent third-party lab testing on request.

Lacticaseibacillus rhamnosus GG — widely known simply as LGG — is one of the most extensively researched and clinically documented probiotic strains in the world, isolated from naturally fermented dairy and valued for its strong tolerance to gastric acid and bile. At Benefacta, we supply this high-potency strain standardized to 200 Billion CFU/g, giving formulators a dependable, science-backed foundation for premium probiotic products. LGG supports intestinal barrier function and helps maintain a balanced gut microbiome, with a well-established body of research behind its role in digestive comfort and immune system support. Its exceptional survivability through the gastrointestinal tract and broad name recognition among both formulators and consumers make it one of the most trusted probiotic strains available, suited to capsules, tablets, sachets, and functional food and beverage applications. We provide complete traceability and comprehensive documentation — Certificate of Analysis (COA), microbial identity confirmation, and independent third-party lab testing on request — with every batch, ensuring the material meets your specification and full compliance with European quality standards before it reaches your production line.

Akkermansia muciniphila is a next-generation, mucin-degrading gut bacterium increasingly recognized in the microbiome science as a key marker of a healthy gut barrier and metabolic function. At Benefacta, we supply the pasteurized (heat-inactivated) form of this strain, standardized to 300 Billion TFU/g (Total Fluorescent Units, the standard measure for non-viable cell count), offering the same functional benefits associated with the live strain but with significantly improved thermal and storage stability. Because the strain is inactivated rather than live, it is substantially more robust than conventional probiotic strains through processing, formulation, and shelf-life conditions — including high-temperature manufacturing steps and moisture-sensitive formats such as gummies, where live vegetative strains typically require microencapsulation to survive. This makes it a practical choice for brands looking to formulate gut-barrier and metabolic-health products without the stability constraints of traditional live probiotics. We supply this ingredient as a fine, uniform powder suited to capsules, tablets, sachets, functional food and beverage applications, and gummies. As with all our raw materials, we provide complete traceability and full documentation — Certificate of Analysis (COA), microbial identity confirmation, and independent third-party lab testing on request — ensuring the material meets your specification and compliance requirements before it reaches your production line.

Ein klinisch erprobtes, teilweise hydrolysiertes Guarkernmehl (PHGG), das die Verdauung fördert, ohne Blähungen zu verursachen.